UNSPSC 51171613: Aloin

This classification denotes a laxative with the molecular formula C21H22O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W41H6S09F4, chemically known as 1,8-dihydroxy-3-hydroxymethyl-10-(6-hydroxymethyl-3,4,5-trihydroxy-2-pyranyl)anthrone but generally known as aloin, which bears US NIH Compound Identifier 14989. European Medicines Agency schedules Aloin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12795MIG. Most nations schedule aloin under HS 29389000 and SITC 54161.

As of Q4 2014, ALOIN remains the US FDA Preferred Term for this commodity. Aloin bears US NLM identifiers UMLS ID C0051209 and NCI Concept Code C76760. SMILES: O1C(C2C3C(C(=O)C4C2CCCC4O)C(O)CC(C3)CO)C(O)C(O)C(O)C1CO.

UNSPSC 51171613 Aloin is a Commodity code that maps to specimen collection and drug testing services for criminal justice and community corrections oversight. The recent state and local procurement activity under this code centers on immunoassay and confirmatory drug screening (LC/MS/MS and GC/MS methodologies) paired with staffing for collection sites, interactive voice response systems for test notifications, and alternative testing modalities including oral fluid and hair analysis. Issuing bodies soliciting under the code include county corrections departments and their community supervision divisions. The scope of work encompasses both the laboratory analytical work and the operational infrastructure—site staffing, specimen handling, electronic result reporting, and price structures built on per-test models with freight, delivery, and insurance bundled into vendor pricing. Vendors must hold lab certifications from SAMHSA, state drug testing authorities (such as TX DPS), or CAP.

Collin County Community Supervision and Corrections Department in Texas posted RFP 2026-327 for offender specimen collection and drug testing services on September 25, 2026, with an original response deadline of July 23, 2026 and an anticipated award date of August 10, 2026. The contract is valued at approximately $600,000 annually for roughly 25,000 tests and runs two years with three optional one-year renewals. Pricing submissions must follow three service models—screening only, confirmation after screening, or screening with automatic confirmation of positives—and vendors compete on technical qualifications (vendor understanding, firm experience, and client references weighted at 70 points combined) and cost (30 points), with optional Phase 2 demonstrations and interviews available for up to 30 additional points. The county reserves the right to award in whole or in part to multiple vendors.